Page last updated: 2024-09-04

disufenton sodium and u 74006f

disufenton sodium has been researched along with u 74006f in 2 studies

Compound Research Comparison

Studies (disufenton sodium)	Trials (disufenton sodium)	Recent Studies (post-2010) (disufenton sodium)	Studies (u 74006f)	Trials (u 74006f)	Recent Studies (post-2010) (u 74006f)
114	19	15	362	49	11

Protein Interaction Comparison

Protein	Taxonomy	u 74006f (IC50)
5-hydroxytryptamine receptor 4	Cavia porcellus (domestic guinea pig)	0.718
Tyrosine-protein kinase Fyn	Homo sapiens (human)	1.116
Alpha-2C adrenergic receptor	Homo sapiens (human)	7.898
5-hydroxytryptamine receptor 2A	Homo sapiens (human)	2.002
5-hydroxytryptamine receptor 2C	Homo sapiens (human)	0.718
Mitogen-activated protein kinase 14	Homo sapiens (human)	7.406

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashwood, T; Green, AR	1
Arba, F; Balami, JS; Buchan, AM; Kleinschnitz, C; Minnerup, J; Sutherland, BA	1

Reviews

2 review(s) available for disufenton sodium and u 74006f

Article	Year
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2 Topics: Animals; Antioxidants; Antipyrine; Azoles; Benzenesulfonates; Brain Ischemia; Edaravone; Free Radical Scavengers; Humans; Isoindoles; Mice; Mice, Mutant Strains; Neuroprotective Agents; Nitrogen Oxides; Organoselenium Compounds; Pregnatrienes; Rats; Reactive Oxygen Species; Stroke; Treatment Failure; Treatment Outcome	2005
Neuroprotection for ischaemic stroke: translation from the bench to the bedside. International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:5 Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical	2012

Article

Year

Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.

Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2

Topics: Animals; Antioxidants; Antipyrine; Azoles; Benzenesulfonates; Brain Ischemia; Edaravone; Free Radical Scavengers; Humans; Isoindoles; Mice; Mice, Mutant Strains; Neuroprotective Agents; Nitrogen Oxides; Organoselenium Compounds; Pregnatrienes; Rats; Reactive Oxygen Species; Stroke; Treatment Failure; Treatment Outcome

2005

Neuroprotection for ischaemic stroke: translation from the bench to the bedside.

International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:5

Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical

2012